Kala Pharmaceuticals, Inc. (16)

Browse by Contract Category

Contracts

Exclusive License Agreement, dated November 10, 2009, by and between the Registrant and The Johns Hopkins University, as amended by the First Amendment dated November 19, 2012,... (Filed With SEC on August 5, 2021)
Settlement and License Agreement, dated October 24, 2014, by and between the Registrant and GrayBug, LLC (Filed With SEC on August 5, 2021)
Loan and Security Agreement, dated May 4, 2021, by and among Kala Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on May 5, 2021)
Form of Employee Restricted Stock Unit Award under 2017 Equity Incentive Plan (Filed With SEC on August 6, 2020)
Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on February 12, 2020)
Third Amended and Restated Registration Rights Agreement of the Registrant dated April 4, 2016, as amended by Amendment No. 1 dated December 13, 2017, of the Registrant (Filed With SEC on February 25, 2021)
Amendment No. 1 to Amended and Restated Master Services Agreement, dated August 25, 2020 by and between the Registrant and Altasciences company (formerly Alliance Contract Pharma,... (Filed With SEC on February 25, 2021)
Amendment No. 3 to Commercial Supply Agreement, dated December 11, 2020, by and between the Registrant and Catalent Pharma Solutions, LLC (Filed With SEC on February 25, 2021)
Fifth Amendment to Exclusive License Agreement, date July 6, 2020, by and between the Johns Hopkins University and the Registrant (Filed With SEC on August 6, 2020)
Form of Non-Employee Director Restricted Stock Unit Award under 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
Amendment No. 2 to Commercial Supply Agreement, dated March 27, 2020, by and between the Registrant and Catalent Pharma Solutions, LLC (Filed With SEC on May 7, 2020)
Form of Non-Employee Director Deferred Restricted Stock Unit Award under 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
Underwriting Agreement, dated March 10, 2020, by and among Kala Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of... (Filed With SEC on March 12, 2020)
Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on May 9, 2019)
Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on March 12, 2019)
Form of Amendment to Offer Letters (Filed With SEC on March 12, 2019)